WebCHOLBAM (cholic acid) SELF-ADMINISTRATION. Indications for Prior Authorization: Treatment of bile acid synthesis disorders due to single enzyme defects (SEDs) Adjunctive treatment of peroxismal disorders (PDs) including Zellweger spectrum disorders in patients who exhibit manifestations of liver disease, steatorrhea or complications from ... WebJun 23, 2024 · Consider resuming drug at lower dosage when results of liver function tests return to baseline. Restricted Distribution Program Obtain through a specialty pharmacy (Dohmen Life Sciences Services) at 844-246-5226 or may consult the Cholbam Total Care Hub website for specific ordering and availability information ( [Web] ).
Cholbam - Side Effects, Uses, Dosage, Overdose, Pregnancy, …
WebDosage and Administration, Treatment Monitoring: o Treatment with Cholbam should be initiated and monitored by an experienced hepatologist or pediatric gastroenterologist. o Discontinue treatment with Cholbam if liver function does not improve within 3 months of the start of treatment. WebSep 10, 2024 · Cholic acid (Cholbam) is used to treat bile acid synthesis disorders and peroxisomal disorders. Learn about uses, side effects, drug interactions, dosages, warnings, and more. ... Dosage Considerations – Should be Given as Follows: Bile Acid Synthesis Disorders. Indicated for bile acid synthesis disorders due to single enzyme defects (SEDs) switchable polarity solvent
Patient Enrollment Form for CHOLBAM® Total Care Hub
WebMay 1, 2024 · Discontinue treatment with CHOLBAM at any time if there are persistent clinical or laboratory indicators of worsening liver function or cholestasis [see Warnings … WebApr 14, 2024 · All indications for which Cholbam has been prescribed [ Time Frame: 10 years ] Description of all indications for which Cholbam has been prescribed. Eligibility Criteria. Go to Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information. WebCHOLBAM was assessed in patients with peroxisomal disorders including Zellweger spectrum disorders in two trials. Trial 1 was a non-randomized, open-label, uncontrolled trial in over an 18 year ... switchable preamp